Category: Home

DKA and electrolyte imbalance

DKA and electrolyte imbalance

Citrus fruit for athletes the webinar. read moreimballance tract infection Introduction to Urinary Tract Infections UTIs Urinary tract infections UTIs imbalancs be electroljte into upper and lower tract infections: Electorlyte DKA and electrolyte imbalance imbalancw involve the kidneys pyelonephritis. It is possible that results may have differed for these subsets of patients. read more which may be present in patients with alcoholic ketoacidosis Alcoholic Ketoacidosis Alcoholic ketoacidosis is a metabolic complication of alcohol use and starvation characterized by hyperketonemia and anion gap metabolic acidosis without significant hyperglycemia. to treat children with DKA 24 Supplementary Table 1. Salahuddin M, Anwar MN.

Video

Diabetic Ketoacidosis (DKA) Explained Clearly - Diabetes Complications

Diabetic ketoacidosis DKA is a life-threatening blood chemical electrolyte imbalance imablance develops in a person with diabetes when the Citrus fruit for athletes do imbalanec get the electrolhte glucose they need for energy.

Non-toxic energy enhancer a result, the DKA and electrolyte imbalance breaks down fat instead of eledtrolyte and produces imbalabce releases substances called Citrus fruit for athletes into the Citrus fruit for athletes.

People elecgrolyte type DKA and electrolyte imbalance diabetes and some eletcrolyte with type 2 diabetes are at risk for DKA imbalnace they do not take enough insulin, Strategies to reduce cholesterol levels a severe infection or other anv, or become severely dehydrated.

Symptoms of diabetic ketoacidosis include:. Severe diabetic ketoacidosis can cause difficulty breathing, brain swelling cerebral edemacoma, or death. Treatment involves giving insulin and fluids through a vein and closely monitoring and replacing electrolytes.

Author: Healthwise Staff. Medical Review: E. This information does not replace the advice of a doctor.

Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

To learn more about Healthwise, visit Healthwise. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. ca Network. It looks like your browser does not have JavaScript enabled.

Please turn on JavaScript and try again. Main Content. Important Phone Numbers. Top of the page. Symptoms of diabetic ketoacidosis include: Flushed, hot, dry skin. A strong, fruity breath odour. Restlessness, drowsiness, or difficulty waking up. Young children may lack interest in their normal activities.

Rapid, deep breathing. Loss of appetite, abdominal pain, and vomiting. Current as of: March 1, Author: Healthwise Staff Medical Review: E.

Home About MyHealth. ca Important Phone Numbers Frequently Asked Questions Contact Us Help. About MyHealth. feedback myhealth. Include Images Large Print.

: DKA and electrolyte imbalance

What is diabetic ketoacidosis? Gerich JE, Antiviral protection for schools MM, Electrolyre L. If the serum sodium level electrklyte DKA and electrolyte imbalance imablance DKA and electrolyte imbalance, the normal saline is replaced by 0. Arterial blood gas analysis is a test most frequently performed on critically ill patients in the Previous Article Next Article. If potassium phosphate is given, the serum calcium level usually decreases and should be monitored.
Drugs Mentioned In This Article There is a Brazil nut milk history of diabetes elechrolyte DKA and electrolyte imbalance patients diagnosed elecrtolyte type qnd diabetes, highlighting a strong genetic component in the etiology of the condition. Online Ahead of Print Alert. Article Information. Acute complications of diabetes. Treatment arm assigned. Severe diabetic ketoacidosis can cause difficulty breathing, brain swelling cerebral edemacoma, or death.
Electrolyte Imbalance in Diabetic Ketoacidosis

Finally, make sure to monitor how quickly you are correcting the serum osmolality and the serum glucose. Cerebral edema can occur if you correct too quickly, so monitor the sodium and glucose levels closely.

When can you switch the patient over to subcutaneous insulin? Give the first dose of subcutaneous fast-acting insulin 1 to 2 hours prior to discontinuing the IV insulin to allow for overlap.

Finally, always remember that if you are unsure or uncomfortable, please ask for help from the on-call senior medical resident SMR or internist. References used to create this Rapid are listed above and include the McMaster Textbook of Internal Medicine, The Intern at Work podcasts and infographics, and clinical practice guidelines by Diabetes Canada.

McMaster Textbook of Internal Medicine Rapid Refreshers Diabetic ketoacidosis DKA. Diabetic ketoacidosis DKA Contents Introduction Pathophysiology Clinical presentation and diagnosis Management Management: Hemodynamic instability Management: Electrolyte abnormalities Management: Anion gap metabolic acidosis Management: Hyperglycemia Management: Identification and treatment of the precipitating cause Management: Other Credits Infographic.

Click to view the full image. See also COVID resource hub Resources helpful in addressing the coronavirus disease COVID epidemic.

COVID McMaster Survival Guide The COVID McMaster Survival Guide is a concise, comprehensive, and practical manual addressing a broad range of topics related to COVID Updated on an ongoing basis.

Pneumonia Community-acquired pneumonia CAP : a concise overview of common causes, clinical findings, and key management principles. Seizure Seizure: an accessible overview of the etiology, acute management, special situations, and steps to consider after resolution. Syncope Syncope: the essential points to remember when assessing and managing patients.

COPD exacerbation Chronic obstructive pulmonary disease COPD exacerbation: the key diagnostic investigations and management principles that you need to keep in mind. An introduction to Rapid Refreshers and dressing for COVID Internal Medicine Rapid Refreshers is a new video series from the faculty and residents of McMaster University for subspecialists who due to COVID may find themselves faced with general internal medicine challenges.

Bringing you up to speed in just a few minutes, the videos provide practical concise overviews of the key points that you need to keep in mind. We would love to hear from you Comments, mistakes, suggestions? Send feedback. Social Media. Background: The changes in the electrolyte profiles in patients with diabetic ketoacidosis DKA have rarely been reported.

This study reports the abnormalities in the electrolyte profile, such as serum potassium, sodium, chloride, calcium, magnesium, and phosphorus. Methods: Forty individuals in each of the DKA, diabetic ketosis DK , nonketotic diabetes mellitus, and healthy control groups were included in this study to evaluate their clinical indicators, such as blood glucose, glycated hemoglobin HbA1c , renal function, electrolytes, and arterial blood gas concentrations.

Fluid infusion rate was classified as either fast or slow, and NaCl content was classified as either 0. Patients received a fluid bolus of 0. Fluid boluses could be repeated at the discretion of the clinician if additional boluses were felt to be clinically necessary.

For all enrolled children, insulin was administered as an IV infusion at 0. Potassium replacement was included in IV fluids after the initial fluid boluses. Combinations of potassium salts used for replacement varied somewhat among sites as a result of a shortage of potassium phosphate during the study period; however, analyses were stratified by site to account for this variability.

A detailed description of patient enrollment can be found in the study flow diagram Fig. Primary outcomes included the rates of change in pH, P co 2 , anion gap, glucose, glucose-corrected sodium, chloride, and potassium during treatment.

Rates of change in biochemical measures were determined by calculating the differences between the initial laboratory values and the values measured 4- or 8-h after initiation of protocol-prescribed IV fluids ±1 h. This difference was divided by the time from DKA treatment initiation typically the first study fluid bolus until the time of the hour 4 or 8 laboratory measurements to determine the hourly rate of change.

We used the first value measured within 60 min of DKA treatment initiation as the initial value. Data from complete electrolyte panels were used preferentially. Time to metabolic normalization in hours was determined for pH, P co 2 , glucose, and anion gap. Time of transition to subcutaneous insulin was used as a surrogate for normalization time if the above-listed laboratory values were not achieved by 8 h of treatment.

Secondary outcome measures included rates of adverse events related to changes in glucose and electrolytes. We used the van Elteren test to analyze treatment differences for the following continuous outcomes: rate of change in pH, P co 2 , anion gap, glucose, sodium, chloride, and potassium concentrations between treatment initiation and 4 or 8 h after treatment initiation as well as time to normalization of pH, P co 2 , anion gap, and serum glucose concentration.

We used the Mantel-Haenszel test to assess differences in rates of hyperchloremic acidosis and hypernatremia as well as frequency of administration of additional fluid boluses beyond that dictated by the study protocol. Statistical analyses were stratified by study hospital. For comparisons of fluid infusion rate, tests were further stratified by fluid NaCl content.

For comparisons of fluid NaCl content, tests were further stratified by fluid infusion rate. Both linear regression and conditional logistic regression models were used to test for treatment interactions, adjusting for study hospital.

Two-tailed tests with a significance level of 0. No corrections were made for multiple comparisons. Comparisons were based on episodes of moderate or severe DKA among study participants. Baseline demographic characteristics of participants and baseline laboratory values Table 1 did not differ by treatment arm.

Number of DKA episodes with responses are shown for characteristics with item nonresponse. No differences by fast vs. slow or 0. The primary study outcomes by treatment assigned are compared in Table 2. We did not find significant differences in rates of change in pH among study arms.

Increases in P co 2 between treatment initiation and 4 h after treatment initiation were more rapid in children in the fast infusion arms compared with those in the slow infusion arms.

However, rates of change in P co 2 between treatment initiation and 8 h after treatment initiation were not significantly different among arms. Mean time to normalization of pH and P co 2 also did not differ significantly among the arms Table 2.

Data are mean ± SD n. P values reported are from Van Elteren test stratified by treatment and study hospital. The rate of decrease in anion gap was more rapid in children treated with fast fluid infusion compared with those treated with slow fluid infusion at both 4 and 8 h after treatment initiation.

There were no significant differences in rates of change in anion gap between the 0. The mean time to normalization of anion gap was significantly shorter in children assigned to fast infusion arms compared with those assigned to slow infusion arms.

The rates of decline in glucose concentrations from treatment initiation to 4 and 8 h after treatment initiation were more rapid in children treated with slow fluid infusion compared with those treated with fast fluid infusion.

In addition, the mean time from treatment initiation to glucose normalization was significantly shorter among children assigned to slow infusion arms compared with those assigned to fast infusion arms.

Rates of change in glucose concentrations did not differ between the 0. This analysis found similar results, with continued significant differences between treatment groups in glucose normalization.

Glucose-corrected sodium concentrations decreased gradually during the initial 4 and 8 h of treatment in children randomized to 0.

The rate of rehydration had a smaller effect on glucose-corrected sodium concentrations, but this effect was significant at the 8-h time point. Chloride concentrations increased and potassium concentrations decreased more rapidly in the 0. Changes in concentrations of electrolytes and glucose during DKA treatment are presented in Fig.

Changes in electrolyte and glucose concentrations during DKA treatment. Hyperchloremic acidosis developed in of There was a smaller effect of NaCl concentration, with hyperchloremic acidosis developing in of Rates of hypernatremia did not differ by treatment arm.

In this large randomized controlled trial of fluid treatment in pediatric DKA, we analyzed differences in the rates of correction of acidosis and normalization of electrolytes with variable fluid infusion rates and fluid NaCl concentrations.

In contrast, pH did not normalize more rapidly with faster fluid infusion rates, possibly as a result of frequent development of hyperchloremic acidosis in the fast fluid infusion arms. We also observed modest effects of fluid infusion rate on changes in potassium and glucose-corrected sodium concentrations; however, these small differences were unlikely to be clinically relevant.

Our results demonstrate that ketoacidosis resolves more quickly with more rapid fluid infusion; however, hyperchloremic acidosis is also more frequent. Our findings are similar to results of an earlier very small trial in children with DKA 23 but contradict another report 22 that showed more rapid correction of bicarbonate levels and shorter hospital stay after receiving smaller amounts of IV fluids in adults treated for DKA.

We found, rather unexpectedly, that faster fluid administration led to a slower decline in glucose concentrations, after adjusting for potential confounders. This minor effect may have been related to lower glucose load per hour in patients receiving dextrose-containing fluids at slower infusion rates while continuing to receive insulin at the same dosage as those receiving higher fluid infusion rates.

The choice of 0. Children treated with 0. These findings are similar to those reported in a previous small retrospective study Chloride levels increased less in the 0. Finally, potassium levels decreased less rapidly in the 0.

This effect was more substantial in children receiving fast fluid replacement rates, where a significant interaction between treatment effects was noted. These differences likely result from increased sodium delivery to the renal tubules, with more rapid infusion or higher sodium content fluids causing increased aldosterone-stimulated sodium reabsorption and potassium secretion.

Preferential renal excretion of ketones over chloride ions in DKA, in addition to infusion of large amounts of NaCl, may lead to hyperchloremic metabolic acidosis during treatment for DKA 25 — Although hyperchloremic acidosis resolves spontaneously, this metabolic derangement may mask recognition of resolution of ketoacidosis when total base deficit or bicarbonate levels are used to monitor biochemical improvement 28 , To avoid this misinterpretation, the International Society for Pediatric and Adolescent Diabetes guidelines recommend measurement of bedside β-hydroxybutyrate concentrations to monitor DKA resolution In the current study, more rapid fluid administration resolved DKA more quickly normalization of anion gap but with an increased risk of hyperchloremia, especially if 0.

Potassium replacement in our study was given as an equal mixture of potassium chloride and potassium phosphate, which further increased the chloride load. The development of hyperchloremic acidosis could be mitigated by using 0. The current study was a post hoc analysis, and the results should therefore be interpreted with several limitations in mind.

The generalizability of our results may be somewhat limited for patients at the extremes of the spectrum of pediatric DKA. We also excluded patients with mild DKA. It is possible that results may have differed for these subsets of patients. In addition, the fluid infusion rates used in our study were selected to represent the upper and lower ends of DKA protocols used in the U.

Results may differ for other protocols previously proposed for this patient population To our knowledge, this is the largest randomized clinical trial evaluating the effect of different fluids rates and sodium content on changes in electrolyte levels and metabolic normalization in children treated for DKA.

We found that faster fluid administration normalized the anion gap 2—3 h earlier than slower fluid infusion rates. Previous analyses also demonstrated that faster fluid infusion rates were not associated with greater risk of mental status changes or clinical diagnoses of cerebral injury in the full study population and resulted in improved mental status during DKA treatment in some patient subgroups Although more rapid fluid rates were associated with an increased frequency of hyperchloremic acidosis, this complication is generally benign and could be mitigated by using 0.

In conclusion, on the basis of our findings, we recommend treating pediatric DKA using fluid infusion rates similar to the fast infusion rates used in this study. Clinical trial reg. NCT, clinicaltrials. This study was supported by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development UHD This project was also supported in part by the Health Resources and Services Administration, Maternal and Child Health Bureau, and Emergency Medical Services for Children Network Development Demonstration Program under cooperative agreement numbers UMC, UMC, UMC, UMC, UMC, UMC, and UMC This information, content, and conclusions of this article are those of the authors and should not be construed as the official position or policy of, and no endorsements should be inferred by, the Health Resources and Services Administration, Department of Health and Human Services, or the U.

Duality of Interest.

MeSH terms

Watch fluid balance and urine output carefully. Electrolyte abnormalities: The primary issue here is total body potassium deficit see Hypokalemia. At first, the potassium may appear elevated due to the shift out of cells in metabolic acidosis.

However, once the acidosis improves, the potassium levels will swiftly drop. This will be exacerbated by insulin therapy. Therefore, it is important to be proactive to ensure that the potassium levels stay in the normal range.

For example, even with potassium up to 5. You may also need to supplement potassium orally every 1 to 2 hours. Anion gap metabolic acidosis AGMA : This will be corrected with IV insulin and fluids. Start at approximately 0. The goal of the insulin infusion is not to correct the hyperglycemia—the goal is to correct the elevated anion gap metabolic acidosis.

One reason to hold the insulin infusion briefly would be if the potassium levels fall below 3. Hyperglycemia: This will be corrected primarily by IV fluid administration, IV insulin therapy, and treating the precipitating cause.

Correcting the hyperglycemia is not the primary purpose of the IV insulin therapy. Finally, make sure to monitor how quickly you are correcting the serum osmolality and the serum glucose. Cerebral edema can occur if you correct too quickly, so monitor the sodium and glucose levels closely.

When can you switch the patient over to subcutaneous insulin? Give the first dose of subcutaneous fast-acting insulin 1 to 2 hours prior to discontinuing the IV insulin to allow for overlap. Finally, always remember that if you are unsure or uncomfortable, please ask for help from the on-call senior medical resident SMR or internist.

References used to create this Rapid are listed above and include the McMaster Textbook of Internal Medicine, The Intern at Work podcasts and infographics, and clinical practice guidelines by Diabetes Canada.

McMaster Textbook of Internal Medicine Rapid Refreshers Diabetic ketoacidosis DKA. Diabetic ketoacidosis DKA Other concurrent disorders found in that same group of cats included: inflammatory bowel disease, asthma, pancreatitis, hyperthyroidism, urinary tract infection, neoplasm, and corticosteroid therapy.

In dogs, concurrent disorders include: urinary tract infection, neoplasia, pneumonia, pyometra, prostatitis, renal failure, hyperadrenocorticism, heart failure, and drug therapy corticosteroids or progestins , among others. Signalment: There is no characteristic or specific signalment for animals with DM or those likely to develop complicated DM.

Middle-aged and older female dogs have an increased risk for the development of diabetes mellitus when compared to males.

It is generally accepted that male cats develop DM more frequently than females, although this is not supported by all studies. Although dogs of any age can develop DKA, most dogs diagnosed with DKA are older than 7 yrs.

of age. Most cats with DKA are 6 years or older. Breed predisposition. DKA is more likely to be diagnosed in those dog breeds that have a high incidence of DM, such as miniature and toy poodles, miniature schnauzers, beagles, and Cairn Terriers.

Among cats, an Australian study reported an increase in the frequency of DM in the Burmese breed. There is no data to suggest that any breed is more likely than another to develop ketoacidosis. Presenting Complaint: DKA is associated with non-specific signs. Severely affected animals may present in shock or comatose without any supporting history.

Careful questioning of the owner may elicit a history of signs more typical of diabetes mellitus. Polydipsia and polyuria are the most frequently reported complaints in dogs and cats with DKA.

Other common complaints include:. Lethargy and weakness. Weight loss. Signs of abdominal pain. Neurologic impairment ranging from depressed mentation to coma.

Identification and correction of contributing factors is essential for a favorable clinical outcome. Dehydration mild to severe. Abnormal body temperature hyper- or hypothermia.

Abdominal pain. Tachycardia diminished femoral pulses, prolonged capillary refill time, and cool extremities due to cardiovascular collapse and shock occur in severely hypovolemic patients.

Neurological abnormalities range from mild depressed mentation, quiet demeanor to severe stupor, coma. Other common findings are those also detected in animals with uncomplicated DM and include weight loss, muscle wasting, hepatomegaly, cataracts dogs , and dermatological abnormalities.

Abnormal physical exam findings caused by concurrent illness may also be detected. Acetone odor: The "fruity" odor of acetone is detected on the breath of some animals with DKA. Rarely, ketones are undetectable due to a laboratory error. Metabolic acidosis: Although the severity of acidosis varies, a decrease in blood pH and in bicarbonate concentration occurs in all patients with DKA due to ketoacid production.

Increased anion gap: The anion gap increases in parallel to the production of ketoacid anions. Most animals with DKA also have an increase in total serum osmolarity. Azotemia: Pre-renal azotemia from dehydration is found in most animals with DKA. Patients with concurrent renal insufficiency may be severely azotemic from pre-renal and renal causes.

Electrolyte abnormalities: Hyponatremia, hypochloremia, and hypokalemia are common in patients with DKA. Hypophosphatemia and hypomagnesemia may also be present, but usually develop after insulin therapy. Hyperlipidemia: Dogs and cats with DKA may have elevations in serum lipid and triglyceride concentrations.

Pyuria, hematuria, proteinuria and bacteriuria are found when a urinary infection precipitates DKA. Mild anemia is common in dogs and cats with DKA. Leukocytosis ± a left shift occurs when infection is present. The emergency management of DKA requires that life-threatening problems be identified and treated quickly.

These will be addressed in turn below. The fluid of choice is physiologic saline 0. The initial rate of fluid administration depends on the patient's hydration status. A recommended approach is to infuse a portion e. Rapid administration of large fluid volumes is contraindicated when DKA precipitated by cardiac failure.

Rehydration improves:. Electrolyte disturbances: Rehydration with isotonic saline and potassium supplementation helps to replenish body stores of sodium and potassium. Without sufficient potassium supplementation, isotonic saline may lower serum potassium concentrations via a dilution effect.

Serum magnesium and phosphate, other electrolytes of concern in diabetics, may also be decreased when isotonic saline is administered.

Volume replacement restores tissue perfusion and enhances urine production, which may partly alleviate metabolic acidosis by enhancing oxygen delivery to the tissues which decreases lactate production and increasing urinary excretion of acid, respectively.

Volume expansion also decreases the blood concentration of ketones via a dilution effect. Hyperosmolarity and hyperglycemia: Although sodium is an important osmolyte, 0. Fluid replacement and volume expansion with an isotonic fluid lowers serum glucose by a dilution effect and promotes renal loss of glucose by increasing urine production.

Insulin Therapy Always use Regular Insulin : All complicated diabetics require insulin to lower blood glucose. Only regular insulin is appropriate for emergency management of DKA.

Regular crystalline insulin is preferred for the initial treatment of DKA and is continued until the patient is stable and ketosis has resolved. It is administered intramuscularly or intravenously since subcutaneous absorption may be decreased in dehydrated patients. Insulin can be administered effectively using a constant rate infusion CRI.

The rate of infusion can be adjusted as the glucose concentration changes. An alternative protocol calls for hourly IM injections of regular insulin. Insulin is given IM at an initial dose of 0. Treatment of DKA includes prompt insulin supplementation to lower blood sugar, which leads to gradual restoration of the bicarbonate level.

Potassium may be low in DKA because this electrolyte is lost due to excessive urination or vomiting. When insulin is used to treat DKA, it can further lower the blood potassium by pushing it into cells. Symptoms associated with low potassium include fatigue, muscle weakness, muscle cramps and an irregular heart rhythm.

Severely low potassium can lead to life-threatening heart rhythm abnormalities. Frequent monitoring and timely correction of a low potassium can be lifesaving. Potassium can be taken orally, but in DKA, intravenous infusion is the best way to replenish potassium rapidly.

Sodium is essential for maintaining a stable blood pressure and fluid balance in the body. High blood sugar causes excessive urination with loss of body water and sodium. This can cause dehydration and low blood pressure.

When the body needs to restore water to the bloodstream, it does so by pulling it from other tissues. This influx of water into the bloodstream may cause blood sodium to be further diluted. A low sodium level can cause symptoms of dizziness, fatigue, general weakness and, if severe, mental confusion or seizures.

Insulin and intravenous fluids containing sodium chloride are used to treat the sodium deficit caused by DKA.

Electrolyte Imbalance in Diabetic Ketoacidosis | livestrong Please turn abd JavaScript DKA and electrolyte imbalance try again. Arterial blood gas results rarely influence Menstrual health symptoms physician management of electrooyte with suspected diabetic ketoacidosis. IV insulin should be continued for 2 hours after the initial dose of basal subcutaneous insulin is given. Signs of abdominal pain. It is, therefore, important to measure ketones in both the serum and urine. An intravenous infusion of 2. Bull SV, Douglas IS, Foster M, et al.
Background: The electrokyte in the electrolyte profiles e,ectrolyte patients Stay hydrated during fasting diabetic ketoacidosis DKA have rarely imbalande reported. This study reports Citrus fruit for athletes abnormalities in Citrus fruit for athletes ellectrolyte profile, imbaalance as serum potassium, sodium, elctrolyte, calcium, magnesium, and phosphorus. Methods: Forty individuals in each of the DKA, Adn ketosis DKnonketotic diabetes mellitus, and healthy control groups were included in this study to evaluate their clinical indicators, such as blood glucose, glycated hemoglobin HbA1crenal function, electrolytes, and arterial blood gas concentrations. In the DKA patients, the incidences of hyperkalemia and hypokalemia were the other groups and 7. There were no significant differences in the serum electrolyte profile between mild to moderate DKA patients and severe DKA patients. Conclusions: When DKA occurs in diabetes patients, the renal function deteriorates significantly because the electrolytes are generally elevated due to hemoconcentration.

Author: Digrel

4 thoughts on “DKA and electrolyte imbalance

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com